TScan Therapeutics, Inc. (28)

Browse by Contract Category

Contracts

Description of the Registrants securities registered pursuant to Section 12 of the Securities and Exchange Act of 1934, as amended (Filed With SEC on March 9, 2022)
Lease, by and between TScan Therapeutics, Inc. and BXP Waltham Woods LLC, dated November 29, 2021 (Filed With SEC on December 2, 2021)
Employment Agreement, dated July 28, 2021, by and between the Registrant and Zoran Zdraveski (Filed With SEC on November 10, 2021)
2021 Employee Stock Purchase Plan (Filed With SEC on April 30, 2021)
Services Agreement by and between Christoph Westphal and the Registrant, dated October 9, 2018 (Filed With SEC on April 23, 2021)
Non-Exclusive License Agreement by and between the Registrant and Provincial Health Services Authority, dated as of October 15, 2020 (Filed With SEC on April 23, 2021)
Employment Agreement, dated May 4, 2021, by and between the Registrant and Brian Silver (Filed With SEC on May 5, 2021)
2021 Equity Incentive Plan and form of agreements thereunder (Filed With SEC on May 5, 2021)
Form of Underwriting Agreement (Filed With SEC on April 30, 2021)
Employment Agreement, dated April 23, 2021, by and between the Registrant and David Southwell (Filed With SEC on April 23, 2021)
Form of Management Cash Incentive Plan (Filed With SEC on April 23, 2021)
Employment Letter Agreement, dated April 23, 2021, by and between the Registrant and William Desmarais (Filed With SEC on April 23, 2021)
Separation Agreement, dated January 26, 2021, by and between the Registrant and Henry Rath (Filed With SEC on April 23, 2021)
Employment Letter Agreement, dated April 8, 2019, by and between the Registrant and Henry Rath (Filed With SEC on April 23, 2021)
Employment Letter Agreement, dated April 23, 2021, by and between the Registrant and Gavin MacBeath, Ph.D (Filed With SEC on April 23, 2021)
Fourth Amended and Restated Investors Rights Agreement, dated January 15, 2021, by and among the Registrant and the other parties thereto (Filed With SEC on April 23, 2021)
Registration Rights Agreement made as of January 15, 2021 by and between the Registrant and the other parties thereto (Filed With SEC on April 23, 2021)
Amended and Restated Royalty Agreement, dated as of June 12, 2018 (Filed With SEC on April 23, 2021)
Collaboration and License Agreement by and between the Registrant and Novartis Institutes for Biomedical Research, dated as of March 27, 2020 (Filed With SEC on April 23, 2021)
Option & Exclusive License Agreement by and between the Registrant and QIAGEN Sciences LLC, dated as of November 5, 2020 (Filed With SEC on April 23, 2021)
Lease by and between PPF OFF 828-830 Winter Street LLC and the Registrant, dated August 13, 2019 (Filed With SEC on April 23, 2021)
Amended and Restated Exclusive Patent License Agreement by and between the Registrant and The Brigham and Womens Hospital, Inc. dated April 20, 2021 (Filed With SEC on April 23, 2021)
2021 Employee Stock Purchase Plan (Filed With SEC on April 23, 2021)
2021 Equity Incentive Plan and form of agreements thereunder (Filed With SEC on April 23, 2021)
2018 Stock Plan, as amended, and forms of agreements thereunder (Filed With SEC on April 23, 2021)
Form of Indemnification Agreement between the Registrant and each of its directors and executive officers (Filed With SEC on April 23, 2021)
Amended and Restated Nominating Agreement, dated April 22, 2021, by and among the Registrant, Baker Brothers Life Sciences, L.P. and 667, L.P (Filed With SEC on April 23, 2021)
Amendment No. 1 to Services Agreement Services Agreement by and between Christoph Westphal and the Registrant, dated June 24, 2019 (Filed With SEC on April 23, 2021)